Talk to Gani about these topics and more:

• Oncology clinical trials (early phase to post approval)
• Oncology medical affairs
• Pharmaceutical, academic and regulatory interactions

Talk to John about these topics and more:

• Tactics for driving health innovation
• Optimizing market access strategies for new therapies
• Demonstrating value through HEOR
• Drug development life cycle strategies

Talk to Tara about these topics and more: 

• Independent Data Monitoring Committees (IDMCs; also known as Data and Safety Monitoring Boards [DSMBs])
• Best practices in clinical data science and biometrics operations
• Clinical trial design and interim analysis
• Biostatistical consulting and regulatory interaction

Talk to Jay about these topics and more:

• Understanding cardiac safety requirements, including protocol design 
• Sponsor support at FDA meetings 
• Early phase development 
• Working with data and safety monitoring boards 
• Cardiac arrhythmias and electrophysiology  

Talk to Cassie about these topics and more:

• Navigating U.S. regulatory requirements, IND Submission, and Phase 1 startup and conduct 
• Efficiencies and guidance in running Phase 1 of clinical development  
• Understanding cardiac safety requirements and the best cost-saving methods 
• Developing new service programs as needs emerge 
• Rapid operational scaling/growth, strategic planning, and recapitalization 

Talk to Christiane about these topics and more: 

• Process development and cGMP manufacturing for clinical and commercial biopharmaceuticals 
• Navigating international regulatory bodies for global pharmaceutical product releases 
• Nurturing collaborative relationships with client partners to accelerate speed to clinic and market 
• Automation and digitalization in biopharmaceutical manufacturing  
• Trends and predictions in the biopharmaceutical industry